title: Fifteen symposia on microdosimetry: implications for modern particle-beam cancer radiotherapy.
abstract: The objective of microdosimetry was, and still is, to identify physical descriptions of the initial physical processes of ionising radiation interacting with biological matter which correlate with observed radiobiological effects with a view to improve the understanding of radiobiological mechanisms and effects. The introduction of therapy with particles starting with fast neutrons followed by negative pions, protons and light ions necessitated the application of biological weighting factors for absorbed dose in order to account for differences of the relative biological effectiveness (RBE). Dedicated radiobiological experiments in therapy beams with mammalian cells and with laboratory animals provided sets of RBE values which are used to evaluate empirical 'clinical RBE values'. The combination of such experiments with microdosimetric measurements in identical conditions offered the possibility to establish semi-empirical relationships between microdosimetric parameters and results of RBE studies.
authors.affiliation: Université Catholique de Louvain, Cliniques Universitaires St-Luc, Brussels, Belgium.
authors.forename: A
authors.initials: A
authors.lastname: Wambersie
authors.affiliation: Université Catholique de Louvain, Cliniques Universitaires St-Luc, Brussels, Belgium CERN, Geneva, Switzerland Hans.Menzel@cern.ch.
authors.forename: H
authors.initials: H
authors.lastname: Menzel
authors.affiliation: Université Catholique de Louvain, Cliniques Universitaires St-Luc, Brussels, Belgium.
authors.forename: J
authors.initials: J
authors.lastname: Gueulette
authors.affiliation: Université Catholique de Louvain, Cliniques Universitaires St-Luc, Brussels, Belgium Institut de Radioprotection et de Sûreté Nucléaire, FontenayauxRoses, France.
authors.forename: P
authors.initials: P
authors.lastname: Pihet
mesh_terms: D000818:Animals; D003226:Congresses as Topic; D006801:Humans; D055616:Microtechnology / Q000379:methods*; D009369:Neoplasms / Q000532:radiotherapy*; D010315:Particle Accelerators / Q000295:instrumentation*; D011853:Radiobiology; D011874:Radiometry / Q000295:instrumentation* / Q000379:methods; D011879:Radiotherapy Dosage; D012062:Relative Biological Effectiveness